SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-008453
Filing Date
2021-02-11
Accepted
2021-02-11 16:05:44
Documents
47
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1220_citiuspharma.htm 10-Q 250123
2 CERTIFICATION f10q1220ex31-1_citius.htm EX-31.1 10549
3 CERTIFICATION f10q1220ex31-2_citius.htm EX-31.2 10340
4 CERTIFICATION f10q1220ex32-1_citius.htm EX-32.1 5234
  Complete submission text file 0001213900-21-008453.txt   2297260

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ctxr-20201231.xml EX-101.INS 298379
6 XBRL SCHEMA FILE ctxr-20201231.xsd EX-101.SCH 47454
7 XBRL CALCULATION FILE ctxr-20201231_cal.xml EX-101.CAL 36904
8 XBRL DEFINITION FILE ctxr-20201231_def.xml EX-101.DEF 111600
9 XBRL LABEL FILE ctxr-20201231_lab.xml EX-101.LAB 279952
10 XBRL PRESENTATION FILE ctxr-20201231_pre.xml EX-101.PRE 196194
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 21619616
SIC: 2834 Pharmaceutical Preparations